Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Feb 12;23(5):725–734. doi: 10.1158/1055-9965.EPI-13-1017

Table 2.

Risk of Recurrence by PAM50 Intrinsic Subtype

All Recurrences n=370 Early Recurrences (<5 years) n=243 Late Recurrences (5-10 years) n=127

PAM50 Subtype N Events HR Lower 95 CI Upper 95 CI N Events HR Lower 95 CI Upper 95 CI N Events HR Lower 95 CI Upper 95 CI
Luminal A 127 ref 61 ref 66 ref
Luminal B 120 1.94 1.36 2.77 82 2.55 1.68 3.88 38 1.34 0.79 2.28
 Luminal B PATHWAYS 53 1.54 0.99 2.41 52 2.39 1.48 3.86 1 0.14 0.02 1.08
 Luminal B LACE 67 2.42 1.54 3.82 30 2.93 1.67 5.14 37 1.73 0.99 3.04
HER2-E 67 1.63 1.10 2.41 54 2.83 1.83 4.38 13 0.55 0.28 1.09
Basal-like 56 2.10 1.37 3.22 46 3.98 2.47 6.42 10 0.59 0.28 1.23
 Basal-like PATHWAYS 33 3.83 2.33 6.28 33 5.44 3.23 9.15 0
 Basal-like LACE 23 1.29 0.75 2.23 13 2.41 1.23 4.75 10 0.63 0.30 1.33
*

Adjusted for age, race/ethnicity, tumor size, number of positive nodes and grade